Merck KGaA
MKKGY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.36 | -1.63 | 1.79 | -1.27 |
| FCF Yield | 2.19% | 0.26% | 0.06% | 1.20% |
| EV / EBITDA | 26.98 | 34.20 | 35.90 | 48.10 |
| Quality | ||||
| ROIC | 2.31% | 1.73% | 1.87% | 1.56% |
| Gross Margin | 60.42% | 57.60% | 59.56% | 57.20% |
| Cash Conversion Ratio | 1.69 | 0.87 | 0.75 | 1.84 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.24% | -1.29% | -1.53% | -1.64% |
| Free Cash Flow Growth | 759.35% | 284.38% | -95.57% | -20.13% |
| Safety | ||||
| Net Debt / EBITDA | -1.32 | -0.85 | -0.67 | 5.72 |
| Interest Coverage | 9.69 | 11.28 | 12.90 | 13.97 |
| Efficiency | ||||
| Inventory Turnover | 0.47 | 0.50 | 0.47 | 0.52 |
| Cash Conversion Cycle | 183.78 | 176.02 | 178.28 | 183.51 |